Is Teladoc a No-Brainer Buy After the Q1 Meltdown? – The Motley Fool

The panic appears to be overdone.

Cut your losses — You’ve heard the advice; I’ve heard it. And it makes sense. A stock that falls 50% must double just to regain its lost ground. That’s not easy to do.

Many investors are cutting their losses with Teladoc Health (TDOC -38.97%) right now. Shares of the virtual-care leader plunged 47% on Thursday morning after Teladoc reported its first-quarter results on Wednesday following the market close. And this big drop came on the heels of the healthcare stock’s decline of nearly 40% year to date before the first-quarter results were announced.

But for every disenchanted investor selling Teladoc stock, there’s an equally motivated investor scooping up the shares. Is Teladoc actually a no-brainer buy after the first-quarter meltdown?

Parsing the bad news

There were two reasons behind Teladoc’s massive sell-off following its first-quarter update. First, the company posted a jaw-dropping net loss of $6.67 billion, or $41.58 per share. Second,…

Read Full Story: https://www.fool.com/investing/2022/04/28/is-teladoc-a-no-brainer-buy-after-the-q1-meltdown/

The post Is Teladoc a No-Brainer Buy After the Q1 Meltdown? – The Motley Fool first appeared on SEO, Marketing and Social News | OneSEOCompany.com.

source: https://news.oneseocompany.com/2022/04/28/is-teladoc-a-no-brainer-buy-after-the-q1-meltdown-the-motley-fool_2022042818779.html

Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.